A Study of Four Different Oral Tablet Formulations of Lazertinib (JNJ-73841937) in Healthy Adult Participants
Clinical trial NCT05742594 · COMPLETED
Trial details
- NCT number
- NCT05742594
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-03
- Primary completion
- 2023-03-31
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.